This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

CC-7085

Celgene Corporation

Drug Names(s): SelCID CC-7085

Description: SelCIDs are potent, orally available inhibitors of tumor necrosis factor alpha (TNF alpha) and phosphodiesterase type four (PDE 4), cytokines that have been linked to the onset and progression of cancer and inflammatory diseases.


CC-7085 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug